01 Oct 2017
Home
File List, RICO
1988 Steere says Lyme is like a B cell leukemia
Assoc Blogs-n-Webs:
TruthCures.org
badlymeattitude.com/
immune2lies.com/
researchfraud.com/
may12.org
meadvocacy.org/
truthbetoldx81
lymecryme
CrymeDiseaseNorway
crymedisease
theothersideofthestretcher
rjspiritualityandtuth
LymeTruthSite
JC-LilnkedIn
KD-Linkedin.com
LD-LinkedIn
JC-academia.edu
KD-academia.edu
CDC "SPIDER"
Fungal Exosomes Inhibit Apoptosis
IDSA:
"Vaccines serve the mfgs, not their victims"
RICO_filed_USDOJ
BlumenthalAntiTrust Lawsuit
Exosomes, Blebs
Spirochetal_Dementia
PDFs
CDC Admits Fraud, 2016
Dattwyler, 1988
Golightly, 1988
Dressler,
1994
BarbourFish, 1993
Dearborn,
1994
BarbourFishpdf.pdf
Pathogenic Fungi
Bush's warcrimes, Oct 2000
Trainer
170708 |
| |
GO HERE FOR THE LINKS TO THE OTHER FULL
TEXT REPORTS; you need to know
1) what Steere said in 1986 about the testing for Lyme,
2) this (below) Dressler/Steere/Dearborn report, and
3) Steere's "Antigens in Europe" (using bogus high passage G39/40, which is
what Steere used here, below)
This is the Dressler/Steere/Dearborn Method. I
gave it in full text to the FDA
vaccine committee (several copies) along with my submission where I
demonstrate that this Dearborn Conference took place, and that the older
diagnostic standard was different- and it was by Steere, and it reflected Lyme
as a Relapsing Fever organism.
It does not meet the FDA rules for a scientifically valid method.
(google FDA bioanalytical method validation).
It is more akin to the 7 Ton Elephant Rule as regards antibody (species)
detection.
It only detects late Lyme arthritis in a knee as a hypersensitivity reaction-
with the high antibody concentration.
Ask yourselves a question: Does the
Steere's Lupus form of Lyme conform to this?
Here is the bogus part about high concentration (ROC area) equaling greater
accuracy. It does not. This is where Steere claims that high antibody
concentration associated with Lyme arthritis is a validation of the method, when
we know the specificity of each antibody is the accuracy of the test in a
human. If a person has OspA antibody, they have a 100% chance of having Lyme,
and the goal in Methods Development and Validations is to validate a method that
detects the LOWEST concentration of something, reliably.
These idiots say this Lyme test is "sensitive" when obviously is does not
detect LOW concentrations of antibody, if the area of the darkened (absorbance)
means MORE AREA EQUALS MORE (higher) CONCENTRATION OF ANTIBODY. This
Dressler/Steere article is the exact opposite of the truth! This is a bogus
validation and "a bogus article."
|